Aevi Genomic Medicine, Inc. (GNMX) insider have most recently took part in a trading activity. On Aug 23, 2017 Harper Philip R, 10% Owner bought 10,361 shares having total worth of $12,433 at the price of $1.2 per share, following the transaction a total of 5,096,044 shares owned by Harper Philip R. Before this latest buy, Harper Philip R purchased GNMX at 2 other times during the past twelve months, for a total investment of $19.09M at an average of $1.49 per share.
The stock has experienced a total of 1 insider trades in the past three months. These trades include 1 buy trades. Furthermore, over the past 12 months , the stock was traded 4 times by insiders. an employee of the company was the buyer in 4 instances.
|Time Frame||Number of Insider Buy||Number of Insider Sell||Stock Price Change(%)|
Shares of Aevi Genomic Medicine, Inc. (GNMX) traded up 1.67% on Aug 23, 2017, hitting $1.22. 170,907 shares of the company’s stock traded hands. Aevi Genomic Medicine, Inc. has a 52 week low of $1 and a 52 week high of $6.85. The company’s market cap is $0 million.
Aevi Genomic Medicine, Inc. (GNMX) last announced its earnings results on Aug 9, 2017. The company reported -0.22 earnings per share (EPS) for the quarter, higher than the consensus estimate of -0.26 by $0.04. During the same quarter in the previous year, the company posted -0.35 earnings per share.
|earnings per share||-0.22||-0.29|
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018